Illumina Shares Hit 52-Week High Zacks.com Illumina is set to enter emerging markets, the third focus area, where it plans to launch a human leukocyte antigen (HLA) typing product in mid-2014. Earlier this month, the company had signed a deal with Quest Diagnostics Inc. (DGX - Analyst Report), ... |
